Cosmos Health Inc. (NASDAQ:COSM) Short Interest Down 36.1% in October

Cosmos Health Inc. (NASDAQ:COSM) was the recipient of a large drop in short interest during the month of October. As of October 31st, there was short interest totalling 363,500 shares, a drop of 36.1% from the October 15th total of 568,500 shares. Based on an average daily trading volume, of 487,900 shares, the short-interest ratio is presently 0.7 days. Currently, 2.0% of the company’s shares are sold short.

Cosmos Health Trading Down 6.0 %

Shares of COSM stock traded down $0.04 during trading hours on Thursday, reaching $0.65. The company had a trading volume of 236,941 shares, compared to its average volume of 841,097. The company has a 50 day moving average of $0.85 and a 200 day moving average of $0.91. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.35 and a quick ratio of 1.17. The firm has a market cap of $15.20 million, a price-to-earnings ratio of -0.29 and a beta of 5.72. Cosmos Health has a 1-year low of $0.47 and a 1-year high of $1.65.

Cosmos Health (NASDAQ:COSM) last posted its quarterly earnings results on Tuesday, August 20th. The company reported ($0.09) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.14) by $0.05. The company had revenue of $13.21 million for the quarter, compared to the consensus estimate of $15.25 million. Cosmos Health had a negative return on equity of 5.83% and a negative net margin of 38.19%. On average, equities research analysts anticipate that Cosmos Health will post -0.48 EPS for the current year.

About Cosmos Health

Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names.